Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis

• US 6,056,961 A
• Filed: 12/15/1997
• Issued: 05/02/2000
• Est. Priority Date: 12/15/1996
• Status: Expired due to Fees

• Current Assignee: Anne Steinbeck-Klose, David Lavie
• Original Assignee: Anne Steinbeck-Klose, David Lavie
• Inventors: Lavie, David, Steinbeck-Klose, Anne
• Primary Examiner(s): Lankford, Jr., Leon B.
• Application Number:
  US08/990,340
• Time in Patent Office: 869 Days
• Field of Search: 424/195.1, 435/235.1, 514/732, 514/738
• US Class Current: 424/730
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 36/38 Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
• CPC Class Codes: A61P 1/16 for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• CPC Class Codes: A61P 31/12 Antivirals

Abstract

The use of extracts from the plant Hypericum perforatum in the preparation of pharmaceutical compositions for the treatment of hepatitis C, chronic hepatitis C and related viruses, said pharmaceutical compositions comprising at least one extract of the plant Hypericum perforatum and optionally in addition, one or more pharmaceutically acceptable inactive components, selected from, carriers, coatings, diluents and adjuvants.

Claims

1. A method for treating hepatitis C in a patient infected with the hepatitis C virus, comprising administering to said patient infected with the hepatitis C virus, on a daily basis for a period of at least three months, between about 1 to about 5 grams of an extract from the plant Hypericum perforatum, said extract having a total hypericin content between about 0.2% and about 0.4% by weight.

2. A method according to claim 1, wherein said total hypericin comprises pseudohypericin and hypericin in a weight of about 2:

1.

3. A method according to claim 1, wherein the total hypericin content contained in said extract administered to said patient is between about 0.0615 mg and about 1.2 mg total hypericin per kilogram of patient body weight per day.

4. A method according to claim 3, wherein said total hypericin comprises pseudohypericin and hypericin in a weight ratio of about 2:

1.

5. A method according to claim 1, wherein said extract is administered in an amount of about 3 grams of extract per day.

6. A method according to claim 5, wherein said extract has a total hypericin content of between about 0.20% and 0.28% by weight.

7. A method according to claim 1, wherein said extract is contained in a pharmaceutical composition in unit dosage form.

8. A method according to claim 7, wherein said pharmaceutical composition is selected from the group comprising capsules and tablets.

9. A method according to claim 8, wherein the administration of said extract is effected by administering to said patient from two to four dosage units twice or thrice daily, thereby administering from 4 to 12 dosage units daily.

10. A method according to claim 8, wherein said pharmaceutical composition is a slow- or controlled release composition, and the administration of said extract is effected by administering to said patient one dosage unit twice daily, thereby administering two dosage units daily.

11. A method according to claim 8, wherein the administration of said extract is effected by administering to said patient from 1-50 capsules or tablets daily.